| 15.74 Data as of Mar 07 |  +1.29 / +8.93%Today’s Change | 8.40 Today|||52-Week Range 16.28 | -- Year-to-Date |
| Previous close | 14.45 |
| Today’s open | 14.70 |
| Day’s range | 14.41 - 16.28 |
| Volume | 152,232 |
| Average volume (3 months) | -- |
| Market cap | $292.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +300.04% |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 13.26 |
| Today’s change | Today’s % change | |
|---|---|---|
| THLDThreshold Pharmaceut... | -0.09 | -1.74% |
| ADHDAlcobra Ltd | -1.09 | -4.62% |
| CCXIChemoCentryx Inc | -0.13 | -1.79% |
| ATHXAthersys Inc | -0.04 | -1.08% |
| Next reporting date | May 28, 2014 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $15.3M |
| Annual profit (last year) | $3.7M |
| Net profit margin | 23.96% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Rachel K. King |
Chief Financial Officer & Head-Media Relations Brian M. Hahn |
Corporate headquarters Gaithersburg, Maryland |
.
